Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-21 8:05 pm Purchase | 13D | Lineage Cell Therapeutics Inc. LCTX | BROADWOOD PARTNERS L.P. | 42,058,883 19.100% | 75,000 (+0.18%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Lineage Cell Therapeutics Inc. LCTX | BlackRock Inc. | 9,919,800 5.300% | 0 (Unchanged) | View |
| 2024-10-22 3:24 pm Purchase | 13G | Lineage Cell Therapeutics Inc. LCTX | BlackRock Inc. | 9,919,800 5.300% | 9,919,800 (New Position) | View |
| 2024-02-08 6:57 pm Purchase | 13D | Lineage Cell Therapeutics Inc. LCTX | BROADWOOD PARTNERS L.P. | 41,983,883 22.200% | 6,756,610 (+19.18%) | View |
| 2022-07-08 4:57 pm Sale | 13G | Lineage Cell Therapeutics Inc. LCTX | BlackRock Inc. BLK | 3,755,757 2.200% | -6,252,753 (-62.47%) | View |
| 2022-03-25 5:23 pm Purchase | 13D | Lineage Cell Therapeutics Inc. LCTX | BROADWOOD PARTNERS L.P. | 35,227,273 20.700% | 980,106 (+2.86%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Lineage Cell Therapeutics Inc. LCTX | BlackRock Inc. BLK | 10,008,510 5.900% | 10,008,510 (New Position) | View |
| 2021-03-16 5:04 pm Purchase | 13D | Lineage Cell Therapeutics Inc. LCTX | BROADWOOD PARTNERS L.P. | 34,247,167 21.200% | 34,247,167 (New Position) | View |
| 2021-01-08 5:00 pm Sale | 13D | Oncocyte Corp OCX | Lineage Cell Therapeutics Inc. LCTX | 3,297,401 4.900% | -968,503 (-22.70%) | View |
| 2020-04-27 5:28 pm Sale | 13D | Oncocyte Corp OCX | Lineage Cell Therapeutics Inc. LCTX | 4,265,904 6.300% | -1,775,250 (-29.39%) | View |
| 2020-02-14 4:45 pm Purchase | 13D | Lineage Cell Therapeutics Inc. LCTX | GREENBELT CORP | 5,697,875 3.620% | 5,697,875 (New Position) | View |
| 2020-01-06 5:00 pm Sale | 13D | Oncocyte Corp OCX | Lineage Cell Therapeutics Inc. LCTX | 6,041,154 10.000% | -2,383,090 (-28.29%) | View |